Night-Shift Work Duration and Risk of Colorectal Cancer According to and Expression.

Cancer Epidemiol Biomarkers Prev
Authors
Abstract

BACKGROUND: We hypothesized that the risk of colorectal cancer in night-shift workers might be different according to insulin receptor substrate status.

METHODS: Among 77,470 eligible women having night work assessed in the Nurses' Health Study, we documented a total of 1,397 colorectal cancer cases, of which 304 or 308 had available data on and , respectively. We used duplication-method Cox proportional hazards regression analysis for competing risks to calculate HRs and 95% confidence intervals (CI) for each colorectal cancer subtype. We measured tumor or expression by immunohistochemistry (IHC).

RESULTS: Compared with women who never worked night shifts, those working ≥15 years night shifts had a marginal trend of increased overall risk of colorectal cancer ( = 0.06; multivariable HR = 1.20; 95% CI, 0.99-1.45). Longer duration of night-shift work was associated with a higher risk of -positive tumors (multivariable HR = 2.69; 95% CI, 1.48-4.89; = 0.001, ≥15 years night shifts vs. never) but not with -negative tumors (multivariable HR = 0.90; 95% CI, 0.54-1.51; = 0.72; for = 0.008). Similarly, the corresponding multivariable HRs were 1.81 for -positive tumors (95% CI, 0.94-3.48; = 0.06) and 1.13 for -negative tumors (95% CI, 0.71-1.80; = 0.56; for = 0.02).

CONCLUSIONS: Our molecular pathologic epidemiology data suggest a potential role of in mediating carcinogenesis induced by night-shift work.

IMPACT: Although these findings need validation, rotating night shift might increase colorectal cancer risk in women with abnormal insulin receptor pathways.

Year of Publication
2020
Journal
Cancer Epidemiol Biomarkers Prev
Volume
29
Issue
1
Pages
133-140
Date Published
2020 Jan
ISSN
1538-7755
DOI
10.1158/1055-9965.EPI-19-0325
PubMed ID
31666286
PubMed Central ID
PMC6954315
Links
Grant list
R35 CA197735 / CA / NCI NIH HHS / United States
R01 CA151993 / CA / NCI NIH HHS / United States
R01 CA137178 / CA / NCI NIH HHS / United States
K24 DK098311 / DK / NIDDK NIH HHS / United States
K07 CA188126 / CA / NCI NIH HHS / United States
R03 CA176717 / CA / NCI NIH HHS / United States
P50 CA127003 / CA / NCI NIH HHS / United States
K07 CA190673 / CA / NCI NIH HHS / United States
R01 OH009803 / OH / NIOSH CDC HHS / United States
P01 CA087969 / CA / NCI NIH HHS / United States